Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent.
Gangat N, Elbeih A, Ghosoun N, McCullough K, Aperna F, Johnson IM, Abdelmagid M, Al-Kali A, Alkhateeb HB, Begna KH, Elliott M, Mangaonkar A, Matin A, Saliba AN, Hefazi Torghabeh M, Litzow MR, Hogan W, Shah M, Patnaik MM, Pardanani A, Badar T, Murthy H, Foran J, Palmer J, Sproat L, Khera N, Arana Yi C, Yates S, Sneider A, Dworkin E, Patel AA, Bazinet A, Senapati J, Bataller A, DiNardo C, Kadia T, Tefferi A. Gangat N, et al. Among authors: mangaonkar a. Am J Hematol. 2025 Feb;100(2):260-271. doi: 10.1002/ajh.27564. Epub 2024 Dec 13. Am J Hematol. 2025. PMID: 39671248 Free PMC article.
Single cell multiomics reveal divergent effects of DNMT3A and TET2 mutant clonal hematopoiesis in inflammatory response.
Mohammed Ismail W, Fernandez J, Binder M, Lasho TL, Kim M, Geyer S, Mazzone A, Finke CM, Mangaonkar AA, Lee JH, Wang L, Kim KH, Simon VA, Rakhshan Rohakthar F, Munankarmy A, Byeon SK, Schwager SM, Harington JJ, Snyder MR, Robertson KD, Pandey A, Wieben ED, Chia N, Gaspar-Maia A, Patnaik MM. Mohammed Ismail W, et al. Among authors: mangaonkar aa. Blood Adv. 2024 Dec 4:bloodadvances.2024014467. doi: 10.1182/bloodadvances.2024014467. Online ahead of print. Blood Adv. 2024. PMID: 39631069
Venetoclax in combination with hypomethylating agents in chronic myelomonocytic leukemia: a propensity score matched multicenter cohort study.
Tremblay D, Csizmar C, DiNardo CD, Ball S, Rippel N, Hammond D, Kadia TM, Ravandi F, Chien K, Van Hyfte G, Mazumdar M, Saliba A, Mangaonkar A, Lasho T, Al-Kali A, Kremyanskaya M, Feld J, Silverman LR, Komrokji R, Mascarenhas J, Padron E, Garcia-Manero G, Sallman DA, Patnaik MM, Montalban-Bravo G. Tremblay D, et al. Among authors: mangaonkar a. Leukemia. 2025 Jan;39(1):257-260. doi: 10.1038/s41375-024-02466-6. Epub 2024 Nov 12. Leukemia. 2025. PMID: 39533069 No abstract available.
Clinical outcomes of patients diagnosed with SETBP1 mutated myeloid neoplasms.
Jabban Y, Yacout M, Baranwal A, He R, Viswanatha D, Greipp P, Jevremovic D, Bessonen K, Foran J, Palmer J, Saliba AN, Hefazi-Torghabeh M, Begna K, Hogan WJ, Mangaonkar A, Patnaik M, Shah M, Alkhateeb H, Al-Kali A. Jabban Y, et al. Among authors: mangaonkar a. Leuk Lymphoma. 2024 Nov 6:1-10. doi: 10.1080/10428194.2024.2425048. Online ahead of print. Leuk Lymphoma. 2024. PMID: 39504138
Vasculitis associated with VEXAS syndrome.
Sullivan M, Mead-Harvey C, Sartori-Valinotti JC, Kalantari K, Kusne YN, Patnaik M, Mangaonkar AA, Go R, Montes D, Reichard K, Olteanu H, Bois M, Hines A, Warrington K, Koster MJ. Sullivan M, et al. Among authors: mangaonkar aa. Rheumatology (Oxford). 2024 Oct 11:keae550. doi: 10.1093/rheumatology/keae550. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39392442
High-dose IV ascorbic acid therapy for patients with CCUS with TET2 mutations.
Xie Z, Fernandez J, Lasho T, Finke C, Amundson M, McCullough KB, LaPlant BR, Mangaonkar AA, Gangat N, Reichard KK, Elliott M, Witzig TE, Patnaik MM. Xie Z, et al. Among authors: mangaonkar aa. Blood. 2024 Dec 5;144(23):2456-2461. doi: 10.1182/blood.2024024962. Blood. 2024. PMID: 39352751 Clinical Trial.
PHF6 mutations in chronic myelomonocytic leukemia identify a unique subset of patients with distinct phenotype and superior prognosis.
Tefferi A, Fathima S, Alsugair AKA, Aperna F, Natu A, Abdelmagid MG, Csizmar CM, Gurney M, Lasho TL, Finke CM, Mangaonkar AA, Al-Kali A, Pardanani A, Reichard KK, He R, Gangat N, Patnaik MM. Tefferi A, et al. Among authors: mangaonkar aa. Am J Hematol. 2024 Dec;99(12):2321-2327. doi: 10.1002/ajh.27492. Epub 2024 Sep 27. Am J Hematol. 2024. PMID: 39329442
Clonal heterogeneity in STAG2m myeloid neoplasms: the Mayo Clinic experience.
Katamesh B, Nanaa A, He R, Viswanatha D, Greipp PT, Bessonen K, Nguyen P, Jevremovic D, Yi CA, Foran J, Begna K, Gangat N, Mangaonkar A, Saliba AN, Patnaik MM, Hogan WJ, Litzow M, Tefferi A, Shah MV, Alkhateeb HB, Al-Kali A. Katamesh B, et al. Among authors: mangaonkar a. Ann Hematol. 2024 Oct;103(10):4333-4336. doi: 10.1007/s00277-024-05971-x. Epub 2024 Aug 28. Ann Hematol. 2024. PMID: 39196377 No abstract available.
150 results